The week in review

COVID-19-related issues like hydroxychloroquine were still making headlines this week, but the sector was also looking to the post-pandemic future The Pharmacy Guild's Suzanne Greenwood wrote about the issues the Guild has with therapeutic substitution by pharmacists as it stands: substituted products won't attract the PBS subsidy, and the current system does not allow community